Variability analysis and inter-genotype comparison of human respiratory syncytial virus small hydrophobic gene by Ivančić-Jelečki, Jelena et al.
RESEARCH Open Access
Variability analysis and inter-genotype
comparison of human respiratory syncytial
virus small hydrophobic gene
Jelena Ivancic-Jelecki1,2* , Anamarija Slovic1,2, Sunčanica Ljubin-Sternak3,4, Gordana Mlinarić Galinović4,5
and Dubravko Forcic1,2
Abstract
Background: Small hydrophobic (SH) gene is one of the mostly diverse genomic regions of human respiratory
syncytial virus (HRSV). Its coding region constitutes less than 50% of the complete gene length, enabling SH gene
to be highly variable and the SH protein highly conserved. In standard HRSV molecular epidemiology studies, solely
sequences of the second hypervariable region of the glycoprotein gene (HVR2) are analyzed. To what extent do the
strains identical in HVR2 differ elsewhere in genomes is rarely investigated. Our goal was to investigate whether
diversity and inter-genotype differences observed for HVR2 are also present in the SH gene.
Methods: We sequenced 198 clinical samples collected within a limited area and time frame. In this HRSV
collection, rapid and significant changes in HVR2 occurred.
Results: Over 20% of strains from this pool (containing HRSV genotypes NA1, ON1, GA5, BA9 and BA10) would be
incorrectly assumed to be identical to another strain if only the HVR2 region was analysed. The majority of
differences found in SH gene were located in the 5′ untranslated region (UTR). Seven indels were detected, one
was genotype GA5 specific. An in-frame deletion of 9 nucleotides (coding for amino acids 49–51) was observed in
one of group A strains. Fifteen different SH protein sequences were detected; 68% of strains possessed the
consensus sequence and most of others differed from the consensus in only one amino acid (only 4 strains differed
in 2 amino acids). The majority of differing amino acids in group A viruses had the same identity as the
corresponding amino acids in group B strains. When analysis was restricted to strains with identical HVR2
nucleotide sequences and differing SH protein sequences, 75% of differences observed in the SH ectodomain were
located within region coding for amino acids 49–51.
Conclusions: Basing HRSV molecular epidemiology studies solely on HVR2 largely underestimates the complexity of
circulating virus populations. In strain identification, broadening of the genomic target sequence to SH gene would
provide a more comprehensive insight into viral pool versatility and its evolutionary processes.
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Background
Human respiratory syncytial virus (HRSV) belongs to
the Orthopneumovirus genus of the Pnemoviridae family
[1] and has non-segmented RNA of negative polarity as
its genome. The genome is approx. 15,200 nucleotides
(nts) long, comprising 10 genes that encode for 11 pro-
teins. The HRSV strains are divided into groups A and B
based on genetic and antigenic differences [2].
There are three proteins on the surface of mature
HRSV virions: glycoprotein (G), fusion protein (F) and
small hydrophobic (SH) protein. SH protein is present
at very low amounts [3, 4]. G and F are important for
attachment and fusion with the target cell, respectively
[5, 6] and they can elicit the production of neutralizing
antibodies [7, 8].
SH protein is a short transmembrane protein (typically
64 amino acids for group A and 65 for group B) that is
anchored by a hydrophobic signal-anchor sequence near
the N-terminus, with the C- terminus oriented extracel-
lularly. The SH ectodomain is only weakly immunogenic
[4, 9]. In infected cells, SH protein accumulates mostly
in lipid rafts of the Golgi and of the endoplasmic
reticulum [3]. It is a viroporin, forming a transmem-
brane pentameric ring that functions as a channel for
cations and small molecules [10, 11]. HRSV SH protein
blocks or delays apoptosis through inhibition of the
TNF-α signalling pathway [12] but the mechanism is still
not fully elucidated.
In molecular epidemiology studies, HRSV surveillance
and genotyping are based on sequences of the second,
C-terminal hypervariable region of the G gene (HVR2).
In frame duplications of 72 and 60 nts have occurred
within this region, leading to emergence of group A
strains belonging to genotype ON1 (which originated
from NA1, and was firstly detected in 2010 [13]) and of
group B strains belonging to BA genotypes, respectively.
To what extent do the strains identical in HVR2 differ
elsewhere in their genomes is rarely investigated. In the
analysis by Agoti et al. such strains differed by at least 1
and up to 9 nts across the complete genome [14].
Next to HVR2, the most diverse HRSV genomic region
is the SH gene [15]. Unlike all other HRSV genes, the
SH coding region constitutes less than 50% of the
complete gene length (the coding regions of other HRSV
genes constitute ca. 75–99% of the gene length). Follow-
ing our previous analysis of HVR2 sequences of strains
detected within a limited geographical area (the Zagreb
region) and limited time frame (March 2011 to March
2014) [16], the goal of this study was to investigate
whether virus variability and inter-genotype differences
observed for HVR2 are also present in the SH gene.
Within this pool of viruses, rapid and significant genetic
changes have occurred in HVR2 [16]. The subset of
strains analysed in this research belong to 3 HRSV A
(NA1, ON1 and GA5) and 2 HRSV B genotypes (BA9
and BA10) and it included all the genotypes that were
detected in Zagreb, 03/2011–03/2014. These are also the




Nasopharyngeal secretions were obtained from children
who were in-patients with acute respiratory infections,
hospitalized mostly due to bronchiolitis or pneumonia
[16]. Based on the availability of the material, 220 sam-
ples with previously determined sequences of the HVR2
region and genotype [16] were chosen for SH gene ana-
lysis. Sequences were obtained from 198 samples.
Reverse transcription, PCR and sequencing
Total RNA was extracted from 500 μL of clinical sam-
ples according to the method reported by Chomczynski
and Mackey [17]. Reverse transcription was performed
at 42 °C for 60 min, in a reaction mix containing 10 μL
of isolated RNA, 1× PCR buffer (GE Healthcare, UK),
0.1 mM of each dNTP, 20 U of RNase inhibitor (Thermo
Fisher Scientific, USA), 1.25 mM MgCl2, 2.5 mM of ran-
dom hexanucleotide primers and 50 U of MuLV reverse
transcriptase (Thermo Fisher Scientific, USA) in a final
volume of 20 μL.
Nested PCR was carried out with two sets of primers.
For the first amplification, forward SH1 (5′ CACA
GTKACTGACAAYAAAGGAGC 3′) and reverse F164
(5′ GTTATGACACTGGTATACCAACC 3′) primers
were used, followed by the second amplification with the
SH3 (5′ CAGATCATCCCAAGTCATT 3′) and SH4 (5′
TGATTGAGAGTGTCCCAGGT 3′) primer pair for
HRSV A strains and the SH5 (5′ AGCCATTGTCTGCC
AGAYCTAGAG 3′) and SH4 primer pair for HRSV B
strains.
Ten microliters of the reverse transcription reaction
mix was used for the first amplification, whereas 2 μL of
the first amplification mixture was used for the second
PCR. PCR reaction mixtures contained 1× PCR buffer
(GE Healthcare, UK), 10 μM of each dNTP, 0.25 mM
MgCl2, 0.25 μM of each primer and 5 U of Taq polymer-
ase (GE Healthcare, UK). PCR conditions for the first
amplification were: 95 °C for 5 min, 40 cycles of 95 °C/
30 s, 50 °C/30 s, 68 °C/2 min, followed by final extension
at 68 °C for 7 min. The second PCR was performed
under the same conditions, except the primer annealing
temperature was 52 °C, and the extension step was
shortened to 1 min.
The amplification products of ca. 600 nts were sepa-
rated on a 1.5% agarose gel. Sequencing reactions were
set up with gel purified DNA, one of the specific primers
used in the second PCR and a BigDye Terminator
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v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific,
USA) according to the manufacturer’s protocol. Sequen-
cing and sequence analysis were performed on a 3130
Genetic Analyzer (Thermo Fisher Scientific, USA). Ob-
tained sequences were submitted to National Center for
Biotechnology Information (NCBI) database, under acc.
Nos. MF479446 - MF479565 (HRSV A) and MF479566 -
MF479643 (HRSV B).
The HRSV genomic region used in the analyses (re-
ferred to as SHseg) spanned bases 4172–4642 of strain
A2 (acc. no. M11486) and 4218–4689 of B1 (acc. no.
AF013254), which are the prototype strains of group A
and B, respectively.
Collection of HVR2 sequences
HVR2 sequences included in this study are a subset of se-
quences determined during our previous study on HRSV
molecular epidemiology [16]. HVR2 region spanned bases
5274–5543 of strain A2 and 652–981 of BA4128/99B. The
length of HVR2 is 270 or 242 nts for group A and 270 or
330 nts for group B.
Sequences retrieved from NCBI database
All available HRSV sequences that possessed AAAA
AAGTCA at the end of SH 3′ untranslated region
(UTR) and beginning of SH-G intergenic region were
downloaded from NCBI database. Besides the 3 strains
sequenced in this study, 14 sequences were found, acc.
Nos. KF826826, KJ672447, KJ672462, KJ672474,
KJ672479, KJ672483, KU950473, KU950479, KU950487,
KU950501, KU950564, KU950609, KU950616 and
KX765891.
Multiple sequence alignments and analyses
Sequences were aligned using BioEdit, version 7.2.5 and
ClustalX 2.1. Sequence conservation (defined as the per-
centage of genomic positions identical in all strains; gaps
were ignored during computing) and mean p-distance
(proportion of nucleotide sites at which two sequences
being compared are different) were calculated using
MEGA software v6.06.
The ratio of the number of non-synonymous substitu-
tions per non-synonymous site and synonymous substi-
tutions per synonymous site (dN/dS) was calculated
with the single-likelihood ancestor counting method
(SLAC) available on the Datamonkey server (http://
www.datamonkey.org/).
Phylogenetic analysis
Phylogenetic trees were generated using the maximum
likelihood method with MEGA software v6.06, under
the most appropriate model of nucleotide substitution
determined with jModeltest v2.1.4. Bootstrap probabil-
ities for 1000 iterations were calculated to evaluate
confidence estimates. Values higher than 70% were con-
sidered significant.
Selective pressure and glycosylation analysis
Codon-based analysis of selective pressure for SH gene
sequences was performed using the HyPhy package
available on the Datamonkey server. Four different
methods were used: SLAC, fixed-effects likelihood, in-
ternal branch fixed-effects likelihood and mixed effects
model of evolution. Sites were considered positively or
negatively selected if (a) they met the cut-off criteria of
p-value of < 0.1; or (b) they were recognized by at least
two methods.
NetOGlyc 4.0 server (http://www.cbs.dtu.dk/services/
NetOGlyc/) and NetNGlyc 1.0 servers (http://www.cbs.
dtu.dk/services/NetNGlyc/) were used for O- and
N-glycosylation site prediction, respectively.
Results
Sequence variability and phylogeny
The SHseg spanned the entire SH gene (coding, 5’ UTR
and 3’ UTR), SH-G intergenic region and G gene 5’ UTR
(Fig. 1). We obtained sequences of 120 HRSV A strains;
83, 34 and 3 were NA1, ON1 and GA5 strains, respect-
ively. Seventy-eight sequences belonged to HRSV B group;
77 belonged to genotype BA9 and 1 to BA10. The nucleo-
tide length of the consensus sequence was 469 nts for
group A and 472 nts for group B strains. Seven indels
were detected (Fig. 1). In group A deletions were at posi-
tions 4190, 4318–4316, in poly A tail (4577–4581) and at
positions 4582–4583 in reference to the consensus se-
quence A2; insertions were an additional adenosine in
poly A tail and a guanosine after nucleotide 4581 (Fig. 1).
In group B, a deletion of an adenosine in poly A tail was
observed (position 4626–4630 in reference to the consen-
sus sequence B1). Five indels were found only within a
single genotype, but in very low percentages. Deletion of 2
nts at the beginning of the SH-G intergenic region in GA5
strains, preceded by 6 adenosines1 was found in 100% of
our GA5 strains and only in GA5 genotype (and therefore
could be classified as genotype specific). Our viral pool
contained only 3 GA5 strains, identical in both HVR2 and
SHseg and all collected in February 2014. Therefore we
searched for other HRSV sequences that possess AAAA
AAGTCA at the end of SH 3’ UTR and beginning of
SH-G intergenic region in NCBI database. Fourteen se-
quences were retrieved and all belong to genotype GA5
(Additional file 1: Figure S1).
We analysed if viruses with identical HVR2 sequences
(considered to be identical viruses in standard molecular
evolutionary analyses) had differences in SHseg. Some
strains identical at HVR2 differed at SHseg, and vice
versa, strains different at HVR2 were identical at SHseg
(Table 1, Additional file 2: Table S1). In our HRSV pool,
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if strains were inferred as being the same based only on
HVR2 sequence analysis, 44 strains (22.3%) would have
been falsely characterized.
As expected, none of SHseg sequences found among
HRSV A strains was detected within HRSV B pool, but
there was also no overlapping between the genotypes. I.
e., none of the SHseg sequences present in any of the 5
HRSV genotypes included in the study were detected in
strains belonging to another genotype.
The phylogenetic analysis based on SHseg (Fig. 2) did
not discriminate NA1 and ON1 genotypes. NA1 and
ON1 strains were placed within a common clade, sepa-
rated from GA5 strains and from group B lineage. In
group B, a single BA10 strain is positioned among the
BA9 strains (Fig. 2).
Nucleotide variability
We calculated the percentage of conservation and mean
p-distance within complete HVR2, complete SHseg and
within each individual region of the SHseg (Table 2).
Compared to HVR2, SHseg showed higher sequence
conservation in all genotypes. Difference in variability
was especially evident when solely the coding region of
the SH gene was compared to HVR2 (HVR2 consists of
96.5% of coding region (for ON1), 95.6% or 96.7% (for
NA1) and 90.9% or 97.3% (for BA9)). The evolutionarily
newest genotype ON1 showed the highest conservation
percentage and the lowest p-distance values (not taking
into account 3 GA5 strains). When individual genomic
regions within SHseg were compared, differences among
genotypes were observed: all HRSV A strains were iden-
tical at the 5’ UTR of the G gene, but ON1 strains
showed a smaller percentage of conserved sites in the 5’
UTR of the SH gene, compared to other regions. In
NA1 strains, the conservation percentage was similar
throughout the SHseg (differing by no more than 4.6%,
excluding the 5’ UTR of the G gene). Among BA9
strains, a smaller percentage of conserved sites was again
observed in the 5’ UTR of the SH gene, while the values
for other regions were comparable.
Fig. 1 Variations in length detected in SHseg. Variations in group A strains are shown in white rectangles; in group B strains in gray. Underlined
sequences are consensus sequences. The percentage of strains possessing presented non-consensus sequences is shown. Asterisks indicate that
both variations were in the same NA1 strain
Table 1 Comparison of HRSV sequence clustering based on HVR2 vs clustering based on SHseg
HRSV group A B
genotype NA1 ON1 GA5 BA9 BA10
total no. of strains 83 34 3 77 1
of different HVR2 sequences 37 22 1 31 n.a.a
no. of different SHseg sequences 30 20 1 21 n.a.
no. of strains identical at HVR2 that
are also identical at SHseg (divided
in groups of identical sequences)
45
(3 + 2 + 6 + 2 + 3 + 2 + 13
+3 + 2 + 3 + 2 + 2 + 2)
14




(5 + 8 + 8 + 2 + 2 + 15 + 2 + 2)
n.a.
no. of strains possessing unique
sequences at HVR2 and at SHseg
11 11 0 7 n.a.
no. of strains identical at HVR2 and
different at SHseg (divided in groups
of identical HVR2 sequences)
19
(4 + 2 + 2 + 4 + 5 + 2)
8
(2 + 2 + 2 + 2)
0 17
(2 + 2 + 2 + 2 + 4 + 3 + 2)
n.a.
no. of strains identical at SHseg and
different at HVR2 (divided in groups
of identical SHseg sequences)
26




(3 + 6 + 4 + 6 + 3 + 2 + 2 + 2)
n.a.
an.a. not applicable
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Unlike group A, the 5’ UTR of the group B G gene
was not completely conserved, but the only difference
among 78 strains was in the last nucleotide of this re-
gion; 60% of strains had a cytosine and 40% an adenine.
Variability of protein sequences
The strains analysed in this study possessed 10 and 5
different SH protein sequences in the HRSV A and
HRSV B strains, respectively (Fig. 3). The SH protein se-
quences identical to the group A or B consensuses was
obtained in 67.7% of strains. The others differed from
the consensuses in only one amino acid (Fig. 3), with
two exceptions: a) the 3 GA5 strains differed in 2 amino
acids; b) in a single strain, RSV5–13 belonging to geno-
type NA1, amino acids 49–51 are missing. A single
N-glycosylation site was predicted for all strains (the
same one, Fig. 3); no potential O-glycosylation sites were
recognised.
In the intracellular and transmembrane protein region
(amino acids 1–41), variability was seen only in group A
strains and 4 out of 5 observed differences were such
that differing amino acids had the same identity as cor-
responding amino acid in group B strains (shaded areas
in Fig. 3). Sequence coding for the fifth amino acid dif-
ference, S35F, observed in only one ON1 strain (HR226–
14 from 2014), presents so far a unique SH gene se-
quence, when compared to all sequences available in
open public databases.
Greater versatility, including the deletion of 3 amino
acids, was observed in the SH ectodomain. Again, two
amino acid differences observed within HRSV A strains
were such that differing amino acids had the same iden-
tity as the corresponding amino acids in group B strains
(shaded areas in Fig. 3). Among the HRSV B strains, dif-
ferences in the amino acid sequence were seen only
within the SH ectodomain. Out of 9 amino acid differ-
ences observes in the SH ectodomain (in both groups,
Fig. 3), 5 were in protein region 49–51.
The codon-based analysis of selective pressure did not
identify any positively selected codon and the mean dN/
dS values were low: 0.13, 0.29 and 0.15 for the NA1,
ON1 and BA9 genotypes, respectively, indicating that
substitutions are not favoured and are purified from the
population.
The last analysis was restricted to strains identical in
HVR2 nucleotide sequences and differing in SH protein
Fig. 2 Phylogenetic analysis based on SHseg. The tree was
generated using the Maximum Likelihood method, General Time
Reversible model. The numbers are bootstrap values determined for
1000 iterations; the tree was condensed using a cut-off value of
70%. Strain genotypes (determined by phylogenetic analysis based
on HVR2) are shown next to strain names. Blue background
indicates group B strains
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sequences. Eight groups of such strains were identified
(Table 3), in 4 of them the differences were in the SH
ectodomain. From those 4, in 3 groups (2 HRSV A and
1 HRSV B), the differences were located within the SH
protein region 49–51, including the case where these 3
amino acids were missing.
Discussion
Due to the fact that SH gene UTRs are relatively long
(when compared to the coding region of the gene) and
that the majority of mutations occur in them, HRSV SH
gene is characterized by high variability while the SH
protein remains highly conserved.




HVR2 SHseg individual SHseg genomic regions

















a 88.0 91.5 81.0 94.4 90.2 90.9 100
b 0.017 0.007 0.019 0.004 0.009 0.007 0
NA1 (83)
a 78.5 89.8 88.1 91.3 88.6 86.7 100
b 0.028 0.015 0.025 0.011 0.018 0.007 0
overallb (120)
a 67.3 79.4 71.4 85.1 76.5 71.1 100
b 0.038 0.018 0.029 0.012 0.023 0.013 0
B BA9 (77)
a 81.5 89.6 78.8 93.9 89.2 90.9 93.3
b 0.023 0.020 0.040 0.011 0.021 0.015 0.032
overallc (78)
a 78.8 87.5 76.5 92.9 88.5 79.5 93.3
b 0.023 0.020 0.040 0.011 0.021 0.017 0.032
aUTR, untranslated region
bgroup A includes strains belonging to ON1, NA1 and GA5 (3 strains identical in HVR2 and in SHseg)
cgroup B includes BA9 strains and a single BA10 strain
Fig. 3 Alignment of deduced SH protein sequences. Dashed line, solid black line and blue line rectangles indicate 10 residue-long conserved
fragment in the cytoplasmic domain Torres et al. [32], transmembrane region Li et al. [30] and a putative antigenic site, respectively. Asterisk
shows the position of stop codons; − indicates gap. Black dot shows predicted N-glycosylation site. Blue shadings indicate amino acids that differ
from the most common one in group A and have the same identity as corresponding amino acids in group B strains
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Besides the complete SH transcript, the genomic seg-
ment we analysed also included its two downstream re-
gions, stopping immediately before the start codon of
the G protein mRNA. The last two regions were in-
cluded because they are known to play a role in the tran-
scriptional regulation of both upstream and downstream
genes [18–20].
We analysed whether a difference in the diversity of
the SH/G junction (i.e. of the sequences between the
stop codon of the upstream gene and the start codon of
the downstream gene) among HRSV genotypes could be
observed. A sequence characteristic only for GA5 strains
was observed, but not all previously reported GA5
strains possess this sequence [20]. Whether it represents
an evolutionary novelty, specific for recent GA5 strains
requires further investigation (the oldest GA5 strain in
our analysis was from Mexico, from 2004).
The overall nucleotide diversity of SHseg was investi-
gated using two methods: conservation percentage that
is not influenced by the number of identical sequences;
and p-distance that is, and therefore, defines more pre-
cisely diversity within this particular HRSV population.
The results of both methods were concordant. The level
of genetic diversity observed in SHseg was not compar-
able to the one detected in HVR2, except in the 5’ UTR
of the genotypes with prolonged G gene (ON1 and BA9)
which gained striking dominance within the short time-
span we analysed. On the contrary, the other SH UTR
and SH-G intergenic region showed less variability in
ON1 and BA9 strains, when compared to NA1
genotype.
The current HRSV genotyping and molecular surveil-
lance system is based on HVR2 [21, 22], a quite short
genomic segment. It partitions HRSV strains in over 15
group A and over 20 group B genotypes. Regarding
phylogeny, SHseg in not as informative as HVR2. E.g. in
analyses based on HVR2, ON1 and NA1 strains are
placed on different branches, even when one copy of the
duplicated segment is excluded from the analysis [23].
Still, basing molecular epidemiology studies only on
HVR2 may be quite misleading. In our pool of HRSV
strains, over 20% of them would be incorrectly assumed
to be identical to another strain if only the HVR2 region
was analysed. An alternative HRSV genotyping scheme
has recently been proposed [24], based on the complete
G protein ectodomainwhich is twice longer than HVR2.
Although this would increase the discrimination be-
tween strains, it is still focused solely on one protein
gene. The G gene is non-representative of the HRSV
genome, as it is marked by elevated substitution rates
(attributed to relaxed selective constraints [25]) and a
flip-flop substitution pattern [26]. Broadening the target
genome sequence to SH (whose length in our analysis
was 401–411 nts in group A, 412 or 413 in group B) or
only to SH 5’ UTR (in our analysis, this was a region of
83 or 84 nts in group A, 85 in group B) would provide
better insight into the interrelation between molecular
epidemiology and molecular and evolutionary dynamics.
Table 3 Differences between SH proteins among strains identical at the HVR2 region
Strains identical in HVR2 nucleotide
sequences and differing in SH
protein sequences





HR15–13 A NA1 2 G cytoplasmic
HR186–13 E
HR119–13 A NA1 2 E cytoplasmic
HR129–13 G
HR175–13 A NA1 2 G cytoplasmic
HR372–13 E
HR116–13 A NA1 11 S cytoplasmic
HR134–13 T
HR2033–12 A NA1 49 V ectodomain
HR110–15 A
RSV3234–12 A NA1 49–51 VFH ectodomain
RSV5–13 –
HR40–14 B BA9 49, 51 T, F ectodomain
HR189–14 I, C
HR2154–12 B BA9 60 K ectodomain
HR2253–12 M
Legend:- gap
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After the translation of our genomic sequences, only
15 different protein sequences were obtained. Although
group A and group B strains diverged approximately
350 years ago [27], the majority of amino acids which
differ from the consensus in group A have the same
identity as corresponding amino acids in group B strains.
This indicates that the variability of the SH protein is
not only low, but is also restricted. Based on the fact that
HVR2 has the highest evolutionary rates, we concen-
trated on strains possessing the same HVR2 nucleotide
sequences, but still differing in their SH protein se-
quences. Those are the strains most likely to be highly
similar and therefore we hypothesized that the observed
differences could be a result of selective pressure. Out of
4 sets of strains with differences in the SH ectodomain,
in 3 sets the differences were in SH protein region 49–
51. In fact, besides S35F the only amino acid differences
observed in group A strains which differed from the
group B consensus, were located within 49–51 region.
In our viral pool, which was very limited both geograph-
ically and temporally, 6.7% of group A strains and 51.3%
of group B strains possessed mutation in region 49–51.
Our hypothesis that SH region 49–51 is an antigenic
site still needs confirmation, but the same amino acids
were shown to be highly variable by Lima et al. [28].
Their analysis was performed on strains belonging to
HRSV genotypes different from ours and detected in
Brazil in 2004–2005. Besides finding T49I variability (as
observed by us), P and A at position 49 were also re-
ported among group B strains. Chen et al. [29] detected
variability in the same region in American HRSV strains
from 1998 to 1999 [29]. In group A, the most common
amino acid at position 49 was V (the same as in our ana-
lysis), but I was also observed. Among group B strains,
at position 51, besides the most common amino acid C
and F (the same as in our analysis), Chen et al. also iden-
tified Y [29].
A deletion of 9 nts coding for amino acids 49–51 was
found in the SH gene sequence of an NA1 strain from
January 2013. The deletion was found only in this strain
that caused a bronchiolitis in a 2-month-old child. The
deletion was confirmed by 3 independent RNA isolations
and preparations of DNA for sequencing. During the
same HRSV epidemic, strain RSV3234–12 (from No-
vember 2012) was detected in a sample from a
4-month-old child with bronchiolitis. The two strains
are identical in the SH, G an F genes, except for the fact
that RSV3234–12 does not possess this deletion in the
SH gene. Other genomic regions were not sequenced. In
group A strains, H51 (which is missing from RSV5–13)
is a crucial residue in the regulation of SH ion channel
activity [30]. Together with H22, H51 plays a key role in
the opening and closing mechanism of the SH penta-
meric pore, since they are located in strategic places
within the chains, close to the N- and C-termini [30,
31]. An alternative amino acid at position 51 (Y, a
non-basic amino acid) has been reported before, in a
Brazilian GA5 strain from 2004 [28], but so far there
were no reports of the deletion observed in RSV5–13. In
vitro experiments regarding the functionality of the SH
protein from RSV5–13 or modelling studies that would
compare its structure to other HRSV SH proteins have
not been performed.
Conclusions
Basing HRSV molecular epidemiology studies solely on
HVR2 largely underestimates the complexity of circulat-
ing virus populations. In strain identification, broadening
of the genomic target sequence to SH gene would pro-
vide a more comprehensive insight into viral pool
versatility.
Unlike its gene, SH protein is characterized by
intra-group conservation and by highly restricted
inter-group variability except for amino acids 49–51, im-
plicating that this protein region may be relevant for the
antigenicity of the virus.
Endnotes
1All sequences are presented as plus strands, in the 5′
to 3′ orientation.
Additional files
Additional file 1: Figure S1. Phylogenetic tree of RSV strains based on
HVR2 genomic segment. Tree was generated using maximum-likelihood
method, based on the General Time Reversible model and discrete
gamma distributed rates across sites. The scale bar indicates the propor-
tion of nucleotide substitutions per site. Numbers are percentages of
bootstrap values determined for 1000 iterations, only values above 70%
are shown. Strain designations are composed of NCBI GenBank acc. no.,
name and genotype. (PDF 54 kb)
Additional file 2: Table S1. Sequences identical at HVR2 or SHseg. (PDF
82 kb)
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